Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Toru Kimura Ph.D. | Representative Director, President & CEO | -- | -- | 1960 |
| Motoyuki Sakai | Rep. Dir. and EVP of Corp. Plan., Corp. Gov., HR & Acc., Leg. & Comp., Intel. Prop. | -- | -- | 1961 |
| Kimihiro Mizuno | Executive Officer of Legal & Compliance; Intellectual Property & Human Resources | -- | -- | -- |
| Mr. Koichi Kozuki | E.O. of Corp. Reg. Comp. & Q.A., Sr. VP, Hd of C.R.C. & Q.A. Div and Dp. Hd of Japan Bus. | -- | -- | -- |
| Dr. Shigeyuki Nishinaka Ph.D. | Managing Executive Office, VP and Head of Business Development & Management | -- | -- | 1964 |
| Mr. Isao Shimizu | Exec. Off., SVP and Dep. Head of Research and Development Div. of Drug Discovery Research | -- | -- | -- |
| Mr. Kenji Ueno | Executive Officer, Senior VP and Deputy Head of Research and Development Division (CMC) | -- | -- | -- |
| Mr. Hideyuki Harada | Mng. Exe. Off. of Supply Chain Div., SVP, Hd. of Supply Chain Div. & Hd. of Japan Bus. Unit | -- | -- | -- |
| Dr. Tsutomu Nakagawa Ph.D. | Executive Officer, Chief Strategy Officer of Sumitomo Pharma America, Inc. & Director | -- | -- | -- |
| Ms. Yumi Sato | Managing Executive Officer of Research & Dev.Div. and SVP & Head of Drug Deve. Div. | -- | -- | -- |
Sumitomo Pharma Co., Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 4,980
Description
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. It has partnerships with Keio University; RIKEN; Kyoto University; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Corporate Governance
Upcoming Events
January 31, 2025 at 6:30 AM UTC
Sumitomo Pharma Co., Ltd. Earnings Date
Recent Events
March 30, 2023 at 12:00 AM UTC
Ex-Dividend Date